Zurueck zur Suche

Reporte zur Charge UJ674AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1 IL 1 UT 1

VAERS 2502871

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ674AA

gering
Staat
CA
Alter
16,0
Geschlecht
M
Eingang
09.11.2022
Impfdatum
28.10.2022
Beginn
28.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error No adverse event

Symptomtext

an extra dose of PENTACEL was inadvertently administered with no reported adverse event; Initial information received on 01-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 months old male patient who was administered an extra dose of pentacel was inadvertently with no reported adverse event while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); and HEPATITIS A VACCINE INACT (VAQTA). On 28-Oct-2022, the patient received 0.5 mL dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE (formulation, strength not reported; lot UJ674AA and expiry date: 04-Jun-2023) via intramuscular route in unknown administration site for prophylactic vaccination. On 28-Oct-2022, (latency: same day) the patient developed a non-serious an extra dose of pentacel was inadvertently administered with no reported adverse event (extra dose administered) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01347468:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR; VAQTA
Allergien
-
Vorherige Impfungen
-

VAERS 2490893

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ674AA

gering
Staat
IL
Alter
0,3
Geschlecht
F
Eingang
27.10.2022
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

reported that a 4-month old consumer was prescribed DTap, but was given both a DTap and PENTACEL at the same visit with no reported adverse event; Initial information received on 14-Oct-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 4 months old female patient who was prescribed dtap, but was given both a vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, TETANUS VACCINE TOXOID (INFANRIX); PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR); and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE). On 14-Oct-2022, the patient received 0.5ml dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer (strength, formulation, lot number and expiry date was unknown) via intramuscular route in the left thigh for prophylactic vaccination. On 14-Oct-2022, the patient received 0.5ml dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (strength, formulation was unknown, lot UJ674AA and expiry date: 04-Jun-2023) via intramuscular route in the left thigh for Immunization. On 14-OCT-2022 the patient developed a non-serious event of reported that a 4-month old consumer was prescribed dtap, but was given both a dtap and pentacel at the same visit (extra dose administered) (Latency: same day) Action taken : not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
INFANRIX; PREVNAR; ROTAVIRUS VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2416933

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ674AA

gering
Staat
UT
Alter
2,0
Geschlecht
F
Eingang
22.08.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product storage error

Symptomtext

The Hib portion was reconstituted with 0.4% NACL saline but the DTAP portion was not yet administered with no reported adverse event; Initial information on 12-Aug-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 years old female patient who was administered the hib portion which was reconstituted with 0.4% nacl saline but the dtap portion was not yet administered with no reported adverse event while receiving vaccine diphtheria/tetanus/5 HYBRID AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13). On 12-Aug-2022, the patient received 0.5 mL dose of suspect diphtheria/tetanus/5 HYBRID AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine (formulation, strength not reported; lot UJ674AA, U7136AA expiry date: 04-Jun-2023) via intramuscular route in the left thigh for immunization. On 12-Aug-2022, the patient was administered the hib portion which was reconstituted with 0.4% nacl saline but the dtap portion was not yet administered with no reported adverse event (product preparation error) following the administration of diphtheria/tetanus/5 HYBRID AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine. It was reported, "they have administered PENTACEL separately. The Hib portion was reconstituted with 0.4% NACL saline but the DTAP portion was not yet administered as they stop vaccination after they realized they are not doing the right thing". Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-